Concepedia

Eugene Choi

EC

Statistics

Publications

2

Citations

103

H-Index

2

Active since

2018

Affiliations

Novartis (United States)(Current)

Eugene Choi is an author at Novartis (United States) specializing in immunotherapy, cancer immunotherapy, and cell-surface antigen targeting.

Publications per year

2018–2022

2

Publications

2

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma

Dexiu Bu, Reshma Singh, Eugene Choi et al. · Oncotarget · 2018 · 71 citations · Full text

, , +17

BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity

Taylor Hickman, Eugene Choi, Kathleen R. Whiteman et al. · PLoS ONE · 2022 · 32 citations · Full text

, , +17

1–2 of 2